Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P250012/S006

Simplera Sync Sensor

Medtronic MiniMed, Inc. · Decision date Dec 5, 2025

FDA DECISIONP250012/S006

What did the FDA decide?

FDA records P250012/S006 as a supplement to PMA P250012, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Dec 5, 2025.

FDA approval order statement

addition of an alternate manufacturing site for the sensor fabrication processes for the Simplera and Simplera Sync sensors. The Simplera Sensor is a component of the Simplera system. The Simplera Sync sensor is a component of the MiniMed 780G system
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Clinical Chemistry
Decision date
Dec 5, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P250012/S006
Regulatory pathway
PMA supplement
Product code
SFI
Decision code
OK30
Decision date
Dec 5, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Sensor, Glucose, Invasive, Component of automated insulin delivery system.

Product code
SFI
FDA device class
3

For the original device and its historical approval scope, see PMA P250012. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P250012 · Original PMA

    Simplera Sync Sensor, Guardian 4 Sensor

  2. P250012/S001 · Related supplement

    Simplera Sync Sensor, Guardian 4 Sensor

  3. P250012/S003 · Related supplement

    Simplera Sync Sensor, Guardian 4 Sensor

  4. P250012/S004 · Related supplement

    Simplera Sync Sensor, Guardian 4 Sensor

  5. P250012/S006 received

    Application receipt date recorded by FDA.

  6. P250012/S006 · FDA decision

    30-Day Notice

  7. P250012/S005 · Related supplement

    Simplera Sync Sensor; Guardian 4 Sensor

  8. P250012/S010 · Related supplement

    Simplera and Simplera Sync

Timeline entries are records held by MedtechLedger for P250012. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P250012

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic MiniMed, Inc.PMA approvalAug 6, 2025FDA
Medtronic MiniMed, Inc.PMA supplementAug 25, 2025FDA
Medtronic MiniMed, Inc.PMA supplementSep 12, 2025FDA
Guardian 4 SensorP250012/S002
Medtronic MiniMed, Inc.PMA supplementOct 9, 2025FDA
Medtronic MiniMed, Inc.PMA supplementOct 16, 2025FDA
Medtronic MiniMed, Inc.PMA supplementDec 8, 2025FDA
Medtronic MiniMed, Inc.PMA supplementDec 10, 2025FDA
Medtronic MiniMed, Inc.PMA supplementMar 19, 2026FDA
Medtronic MiniMed, Inc.PMA supplementMay 26, 2026FDA
Medtronic MiniMed, Inc.PMA supplementJun 12, 2026FDA
Simplera SyncP250012/S011
Medtronic MiniMed, Inc.PMA supplementJul 21, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic MiniMed, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
18000 Devonshire St., Northridge, CA, 91325

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records